Skip to search formSkip to main content

BT-061

Known as: BT-061MAb 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Regulatory T cells (Tregs) represent a subpopulation of CD4(+) T cells, which are essential for the maintenance of immunological… Expand
Is this relevant?
2016
2016
The humanized non-depleting anti-CD4 monoclonal antibody Tregalizumab (BT-061) is able to selectively activate the suppressive… Expand
Is this relevant?
2015
2015
CD4(+)CD25(+) regulatory T cells (Tregs) represent a specialized subpopulation of T cells, which are essential for maintaining… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
Regulatory T cells (Tregs) represent a subset of CD4+ T cells that express the forkhead box protein 3 factor (FOXP3) in their… Expand
  • figure 1
Is this relevant?
2015
2015
Treatment of PBMC with the CD4-specific mAb BT-061 induces CD4 down-modulation of T cells. Here we report that addition of BT-061… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Background . Regulatory T cells (Tregs) are essential for maintaining normal immune homeostasis. We have previously reported that… Expand
Is this relevant?
2011
2011
Pharmaceuticals have entered into an agreement to co-develop BT-061, a humanized CD4-specific monoclonal antibody that is… Expand
Is this relevant?
2010
2010
Naturally occurring Tregs are essential for maintaining normal immune homeostasis in healthy individuals. In patients with… Expand
  • figure 2
Is this relevant?